Mark Iwicki – Biography
Last update: March 25, 2026Executive profile
Mark Iwicki joined Inhibikase Therapeutics in 2026.
Mark Iwicki is currentlyChief Executive Officer at Inhibikase Therapeutics - View - Inhibikase Therapeutics org chart
Chairman of Board at Q32 Bio - View - Q32 Bio org chart
Director at Nimbus Therapeutics - View - Nimbus Therapeutics org chart
Director at Nocion Therapeutics - View - Nocion Therapeutics org chart
Create your alert
to follow the career of Mark Iwicki.
More about Mark Iwicki
Selected links
Do you need to know more about Mark Iwicki? More results.
Participate
Social media
- Mark Iwicki on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Mark Iwicki
The colleagues of Mark Iwicki
Company Colleagues
- At Inhibikase Therapeutics, Mark Iwicki has 17 colleagues including Vincent Aurentz (Director), Dennis Berman (Director)…
- At Q32 Bio, Mark Iwicki has 24 colleagues including Jodie Morrison (CEO), Diyong Xu (Director)…
- At Nimbus Therapeutics, Mark Iwicki has 23 colleagues including Abbas Kazimi (CEO), Laura Stoppel (Director)…
- At Nocion Therapeutics, Mark Iwicki has 13 colleagues including Richard Batycky (CEO & Director), Pini Orbach (Director)…
Industry Colleagues
- In the Biotechnology industry, Mark Iwicki has 35,832 colleagues in 2,404 companies located in 42 countries. 16,916 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Mark Iwicki.
Get in Touch
Here are a few tips for establishing great contacts.
Through the switchboard,
and ask for Mark Iwicki.
and ask for Mark Iwicki.
